Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker update for breast, colorectal and non-small cell lung cancer.

Drug news & perspectives - 1 Jan 2000

Ross Jeffrey S

Abstract excerpt

The integration of diagnostics into the selection, administration, dosing and monitoring of the use of anticancer drugs has continued to impact the pharmaceutical industry with particular emphasis on cancers of the breast, colon and lung. An update is given on the biomarkers for these cancers.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Neoplastic Cells, Circulating

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 20155222
DOI: 10.1358/dnp.2010.23.1.1437316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20155222-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarker update for breast, colorectal and non-small cell lung cancer.PMID 20155222Read ↗

Cancer molecular markers: A guide to cancer detection and management.Semantic proximity Read ↗

Prognostic and predictive biomarkers in non-small cell lung carcinoma.Semantic proximity Read ↗

Molecular biomarkers for cancer detection in blood and bodily fluids.Semantic proximity Read ↗

The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancerSemantic proximity Read ↗

Market watch: emerging companion diagnostics for cancer drugs.Semantic proximity Read ↗

Cancer. Developing molecular biomarkers for cancer.Semantic proximity Read ↗

Biomarker testing in non-small cell lung cancer: a clinician's perspective.Semantic proximity Read ↗

The World’s Five Deadliest Cancers: Current Trends, Therapeutics, and Future DirectionsSemantic proximity Read ↗

The World’s Five Deadliest Cancers: Current Trends, Therapeutics, and Future DirectionsSemantic proximity Read ↗

Current challenges in lung cancer early detection biomarkers.Semantic proximity Read ↗

The rapidly evolving landscape of biomarker testing in non-small cell lung cancer.Semantic proximity Read ↗

Cancer biomarker that are currently used in cancer therapy and under evaluation in clinical trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.